Safety and Effectiveness of Bexagliflozin in Patients with Type 2 Diabetes Mellitus and Stage 3a/3b CKD.
American Journal of Kidney Diseases（2019）
关键词
Type 2 diabetes,SGLT2 inhibitor,chronic kidney disease (CKD),renal impairment,bexagliflozin,hemoglobin A1c (HbA1c),glucose-lowering therapy,albuminuria,kidney function,estimated glomerular filtration rate (eGFR),randomized controlled trial (RCT)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要